| Tasman Resources Limited (TAS) ORDINARY FULLY PAID |
Materials |
$19 |
Change in substantial holding - 7 Enterprises Pty Ltd
|
13 Feb 2026 9:47AM |
$0.061 |
$0.042 |
fallen by
31.15%
|
|
| WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$206 |
Geoff Wilson Appendix 3Y
|
13 Feb 2026 9:46AM |
$1.165 |
$1.145 |
fallen by
1.72%
|
|
| Ronin Resources Ltd (RON) ORDINARY FULLY PAID |
Materials |
$6 |
Pause in Trading
|
13 Feb 2026 9:45AM |
$0.270 |
$0.160 |
fallen by
40.74%
|
|
RON - Price-sensitive ASX Announcement
Full Release
Key Points
- Pause in trading of Ronin Resources Ltd securities.
- Trading halt pending further announcement.
- Compliance with ASX Listings requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$9 |
Flavocide Acute Neurotoxicity Study Underway
|
13 Feb 2026 9:45AM |
$0.031 |
$0.031 |
fallen by
0%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$200 |
January 2026 Investment Update
|
13 Feb 2026 9:44AM |
$1.030 |
$1.015 |
fallen by
1.46%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$195 |
Form 8-K
|
13 Feb 2026 9:43AM |
$1.090 |
$1.275 |
risen by
16.97%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical reported a net loss of $11.6 million for the fourth quarter of 2025.
- Total revenue for the quarter was $17.6 million, a decrease of 4% compared to the same period in 2024.
- The company secured a new credit facility with Perceptive Advisors LLC for up to $60 million.
- AVITA Medical's full-year 2025 revenue increased by 11% to $71.6 million.
- The gross profit margin for the year was 82.1%.
- AVITA Medical focused on reducing operating expenses and improving cash efficiency.
- The RECELL product continues to gain Medicare reimbursement coverage.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$401 |
Strong Returns Boost Dividend to 8c, Dividend Policy Update
|
13 Feb 2026 9:43AM |
$2.930 |
$2.760 |
fallen by
5.80%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$195 |
AVITA Q4 and FY25 Earnings Presentation
|
13 Feb 2026 9:42AM |
$1.090 |
$1.275 |
risen by
16.97%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Delivered stable revenue performance in Q4 2025.
- Improved reimbursement clarity and utilization normalization at burn and trauma centers.
- Advanced post-market clinical programs for Cohealyx and PermeaDerm.
- Financial results: FY 2025 revenue $71.6M, operating expenses $101.4M, net loss $48.6M.
- Secured new debt facility with Perceptive Advisors LLC to refinance existing debt.
- 2026 growth expectations with revenue guidance of $80 to $85 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alicanto Minerals Limited (AQI) ORDINARY FULLY PAID |
Materials |
$280 |
Cleansing Notice
|
13 Feb 2026 9:42AM |
$2.300 |
$1.730 |
fallen by
24.78%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$195 |
AVITA Reports Q4 and Full Year 2025 Financial Results
|
13 Feb 2026 9:41AM |
$1.090 |
$1.275 |
risen by
16.97%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for Q4 2025 was $17.6 million, a decrease from Q4 2024.
- Full year 2025 revenue was $71.6 million, an 11% increase from 2024.
- Gross profit margin for Q4 was 81.2%, and for the full year was 82.1%.
- Net loss for 2025 was $48.6 million, improved from $61.8 million in 2024.
- The company refinanced its debt under a new facility with Perceptive Advisors.
- Financial guidance for 2026 predicts a 12% to 19% revenue growth.
- AVITA's product RECELL received broader Medicare reimbursement coverage.
- The company focused on improving cash efficiency and reducing costs in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$83 |
Notice Under Section 708A
|
13 Feb 2026 9:41AM |
$0.093 |
$0.069 |
fallen by
25.81%
|
|
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$21 |
Application for quotation of securities - AQX
|
13 Feb 2026 9:41AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$401 |
Dividend/Distribution - RG8
|
13 Feb 2026 9:41AM |
$2.930 |
$2.760 |
fallen by
5.80%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$195 |
Appendix 4E and Annual Report (Form 10-K)
|
13 Feb 2026 9:40AM |
$1.090 |
$1.275 |
risen by
16.97%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss decreased to $48.6 million from $61.8 million.
- Total revenues grew to $71.6 million.
- Cash and cash equivalents amounted to $10.2 million.
- Operating expenses increased, affecting profitability.
- Strategic initiatives focused on market expansion and product development.
- Executed agreements and amendments to bolster operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$83 |
Application for quotation of securities - ALA
|
13 Feb 2026 9:40AM |
$0.093 |
$0.069 |
fallen by
25.81%
|
|
| Evergold Minerals Limited (EG1) ORDINARY FULLY PAID |
Materials |
$9 |
Cleansing notice under section 708A(5)(E) of Corps Act
|
13 Feb 2026 9:39AM |
$0.040 |
$0.027 |
fallen by
32.50%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$205 |
Drilling to Commence at Rocklands
|
13 Feb 2026 9:39AM |
$0.105 |
$0.082 |
fallen by
21.90%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral Resources Australia Ltd (ASX:AR1) announced the commencement of a drilling campaign at Rocklands targeting improved confidence in the Cu-Au mineral resource.
- The drilling will include an 18-hole RC/DDH programme covering 2,567 meters aimed at the Las Minerale and Double Oxide Cu-Au prospects.
- The programme aims to validate the geological and mineralisation controls and improve confidence in the existing Rocklands mineral resource estimate.
- The initiative will also include targeted metallurgical and comminution test work to assess processing assumptions such as flotation response and grinding behavior.
- Austral plans to deliver results progressively through Q3 2026 to support further resource definition and processing optimisation studies.
- The Rocklands Processing Plant is a large-scale Cu-Au sulphide flotation facility with a 3.0 Mtpa capacity, affected historically by throughput imbalances.
- Austral is focused on plant optimisation, addressing debottlenecking opportunities across the circuit, including SAG mill integration.
- The company aims to produce 50,000 tonnes of copper per year from the Mt Isa–Cloncurry region and position itself as a regional processing hub.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$21 |
Application for quotation of securities - AQX
|
13 Feb 2026 9:39AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
| St George Mining Limited (SGQ) ORDINARY FULLY PAID |
Materials |
$491 |
Government Financial Support for Araxa
|
13 Feb 2026 9:39AM |
$0.096 |
$0.125 |
risen by
30.21%
|
|
SGQ - Price-sensitive ASX Announcement
Full Release
Key Points
- St George Mining Limited received government tax exemptions for Araxá Project.
- The project is located in Minas Gerais, Brazil, with significant niobium and rare earths resources.
- Preferential goods tax regime to reduce development costs by up to 18%.
- A joint venture with CEFET to establish a technological centre at Araxá.
- Government support includes a Memorandum of Understanding for developing domestic supply chains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alicanto Minerals Limited (AQI) ORDINARY FULLY PAID |
Materials |
$280 |
Change of Director's Interest Notice x 4
|
13 Feb 2026 9:39AM |
$2.300 |
$1.730 |
fallen by
24.78%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$248 |
US Increases Duties on China Graphite to Over 160%
|
13 Feb 2026 9:39AM |
$0.340 |
$0.288 |
fallen by
15.44%
|
|
| SPDR S&P/ASX Australian Government Bond Fund (GOVT) |
Financials |
$73 |
Product Disclosure Statement
|
13 Feb 2026 9:38AM |
$24.230 |
$23.955 |
fallen by
1.13%
|
|
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$32 |
AuMEGA Metals Announces Brokered LIFE Offering of up to C$10
|
13 Feb 2026 9:37AM |
$0.039 |
$0.036 |
fallen by
7.69%
|
|
AAM - Price-sensitive ASX Announcement
Full Release
Key Points
- AuMEGA Metals Ltd. is launching a brokered LIFE Offering of up to C$10 million.
- Clarus Securities Inc. will act as the lead agent and sole bookrunner.
- The offering will include flow-through shares and common shares.
- Proceeds will fund exploration efforts in Newfoundland, Canada.
- The exploration program will focus on high-priority targets in the Cape Ray District.
- Closure of the offering is expected on or about March 3, 2026.
- The LIFE Offering complies with Canadian tax law requirements.
- AuMEGA aims to expand its resource base through this offering.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$205 |
MBK:MOU With Austral to Assess Toll Treatment of Millennium
|
13 Feb 2026 9:37AM |
$0.105 |
$0.082 |
fallen by
21.90%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral Resources Australia Ltd and Metal Bank Limited (MBK) have entered into a Memorandum of Understanding (MOU).
- The MOU is for the collaborative assessment of the toll treatment of metal concentrate from the Millennium Project.
- The Millennium Project is located in Queensland and involves the processing of copper-cobalt-gold ores.
- Austral Resources' processing facilities will be used for the toll treatment.
- The MOU signifies an evaluation phase to determine the feasibility and benefits of such a partnership.
- This collaboration is expected to provide mutual benefits by leveraging Austral's processing capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Bank Limited (MBK) ORDINARY FULLY PAID |
Materials |
$19 |
MOU With Austral to Assess Toll Treatment of Millennium Ore
|
13 Feb 2026 9:37AM |
$0.028 |
$0.022 |
fallen by
21.43%
|
|
MBK - Price-sensitive ASX Announcement
Full Release
Key Points
- MBK and Austral signed a non-binding MOU for toll treatment of Millennium ore at Rocklands.
- Millennium holds a JORC 2012 Inferred Resource with potential for expansion.
- Rocklands is approximately 19km from Millennium and is being positioned as a regional processing hub.
- The MOU covers technical, commercial, and logistical evaluations.
- The agreement is non-exclusive and contingent on further due diligence.
- Millennium project is a significant copper-cobalt resource in northwest Queensland.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.